J.P. Morgan Private Wealth Advisors LLC - EPIZYME INC ownership

EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 99 filers reported holding EPIZYME INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q4 2017$179,000
-33.9%
14,2430.0%0.00%
-50.0%
Q3 2017$271,000
+13.4%
14,243
-10.2%
0.00%0.0%
Q2 2017$239,000
-12.1%
15,8560.0%0.00%0.0%
Q1 2017$272,000
+41.7%
15,8560.0%0.00%0.0%
Q4 2016$192,000
+23.1%
15,8560.0%0.00%
+100.0%
Q3 2016$156,000
-3.7%
15,8560.0%0.00%
-50.0%
Q2 2016$162,000
-15.6%
15,8560.0%0.00%0.0%
Q1 2016$192,000
-24.4%
15,8560.0%0.00%
-33.3%
Q4 2015$254,000
+24.5%
15,8560.0%0.00%0.0%
Q3 2015$204,000
-46.5%
15,8560.0%0.00%
-25.0%
Q2 2015$381,000
+27.9%
15,8560.0%0.00%
+33.3%
Q1 2015$298,000
-0.3%
15,8560.0%0.00%
-25.0%
Q4 2014$299,000
-30.5%
15,8560.0%0.00%
-33.3%
Q3 2014$430,000
-12.8%
15,8560.0%0.01%
-25.0%
Q2 2014$493,000
-29.9%
15,856
-48.6%
0.01%
-38.5%
Q1 2014$703,00030,8560.01%
Other shareholders
EPIZYME INC shareholders Q2 2016
NameSharesValueWeighting ↓
RP Management, LLC 9,166,667$79,842,00029.97%
Foresite Capital Management III, LLC 998,278$8,695,0007.64%
KPCB XIII Associates, LLC 3,838,166$33,430,0006.87%
Burrage Capital Management LLC 564,555$4,917,0003.98%
Palo Alto Investors LP 6,856,513$59,720,0003.40%
MPM BioImpact LLC 2,331,534$20,308,0002.55%
Foresite Capital Management II, LLC 1,000,002$8,710,0002.00%
Foresite Capital Management I, LLC 293,759$2,559,0001.29%
Redmile Group, LLC 8,824,366$76,860,0001.08%
Rock Springs Capital Management LP 2,802,954$24,414,0000.53%
View complete list of EPIZYME INC shareholders